Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India’s Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.
Slater & Gordon mulls class action over doctors’ ‘excessive’ work hours
ACCC cuts collusion claims as trial against Pacific National, Aurizon comes to an end
Octaviar class action appeal ‘completely misconceived’, Full Court hears
A judge’s decision to halt questioning about ASIC emails in a class action trial over the 2008 collapse of finance group Octaviar didn’t shut the case down, the Public Trustee of Queensland has told the Full Federal Court, calling the appeal of the class action’s dismissal “completely misconceived”.